The use of the tumour marker CA19-9 in evaluating the response to tamoxifen therapy in patients with unresectable adenocarcinoma of the pancreas.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/DA7BFEC7.svg?ark=w1%2F20260515%2FDA7BFEC7)](https://nobleid.org/work/w1/20260515/DA7BFEC7)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors